Could hepatitis c kidneys save lives? new study tests transplant safety
NCT ID NCT04605679
First seen Feb 02, 2026 · Last updated May 15, 2026 · Updated 9 times
Summary
This study looks at whether it is safe and effective to give kidney transplants from donors with hepatitis C to patients on the waiting list who do not have hepatitis C. The goal is to expand the donor pool and reduce wait times. Researchers will track 31 participants for one year after transplant to see how well the kidney and patient survive.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Loma Linda University Health-Transplant Institute
Loma Linda, California, 92354, United States
Conditions
Explore the condition pages connected to this study.